Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre
Dr Shepherd received her medical degree from the University of Toronto, Ontario, Canada and is currently a Senior Staff Physician at Princess Margaret Hospital in Toronto, where she holds the Scott Taylor Chair in Lung Cancer Research. She is a Full Professor of Medicine at the University of Toronto and served as the University Division Director for Medical Oncology from 1997 to 2003.
Dr Shepherd has been recognized for her many contributions in the field of lung cancer research, most notably her long-standing international leadership in the development of innovative therapies for this indication. In 2001, she was named the Scott Taylor Chair in Lung Cancer Research, becoming the first holder of this esteemed research position with a primary goal of investigating new treatments for lung cancer. Dr Shepherd served as Chair of the Lung Cancer Committee of the National Cancer Institute of Canada Clinical Trials Group for 19 years and was President of International Association for the Study of Lung Cancer (IASLC) from 2003 to 2005. She has been a member of the Board of Directors of American Society of Clinical Oncology (ASCO); she is a current Board member of the European Organisation for Research and Treatment of Cancer (EORTC), and chairs the EORTC Protocol Review Committee. Dr Shepherd has served as Chair of ASCO Membership and Publications Committees. She was the recipient of the Jacqueline Seroussi Memorial Foundation for Cancer Research Award in 2004; the National Cancer Institute of Canada O. Harold Warwick Award for Research Excellence in 2006; the IASLC Research Award in 2007; the Ontario Premier’s Summit Award for Research in 2009; and a Boehringer-Ingelheim Innovation Award in 2010. In recognition of her contributions to cancer research and treatment, she received the Order of Ontario in 2007. In 2012, she won the British Thoracic Oncology Group International Award for Contributions to Lung Cancer Research, the Royal College of Physicians and Surgeons of Canada Whiteman Award and Visiting Professor and a Queen Elizabeth II Diamond Jubilee medal. In 2015, she was made an Officer of the Order of Canada.
Dr Shepherd has designed and led more than 100 clinical trials over the past three decades and her studies have changed treatment and outcomes for patients with lung cancer at a global level. She sits on numerous national and international lung cancer advisory boards, and chairs and/or sits on several Data and Safety Monitoring Boards for international lung cancer trials. She has mentored more than 30 post-doctoral research fellows from around the world, many of whom now hold senior academic positions in their home countries. She has authored or co-authored more than 450 peer-reviewed publications and 35 book chapters.
Chief Digital Officer – Health & Wellness, Ogilvy Consulting
Ritesh joined Ogilvy in 2014, as the Chief Digital Officer for Ogilvy CommonHealth. There he worked with the digital team at OCHWW to create the industry’s first marketing cloud that enabled clients to truly have a 360 view of their HCP customer. Ritesh has also led the team here that successfully created an EHR practice enabling clients to directly message HCPs on an EHR platform.
Additionally, Ritesh supported and led the creation of the OCHWW Innovation Lab. The Lab has been responsible for showcasing the art of the possible. Voice-activated systems like Alexa and Google Home, connected homes, wearables, chatbots and AI are the subjects the Lab are focused to showcase how these tools and technologies have and will continue to impact healthcare in the not-too-distant future.
Ritesh consults with major clients on digital transformation and innovation. He is an outspoken digital evangelist who has lent his expert POV in a variety of forums over his 19+ year career. He is passionate about educating his peers and his clients about what the future of digital looks like for healthcare and, in addition to all the innovations he's been responsible for bringing forward, he has taken his mission on the road and speaks at a wide variety of digital and healthcare-centred events across the world.
CEO and Founder of Deep 6 AI
Wout is the CEO and founder of Deep 6 AI, which uses NLP and AI on clinical data to accelerate clinical trial recruitment and analysis. Deep 6 originated in arguably the world’s most complex data environment, the US Intelligence space.
Wout started his career as a diplomat in the Middle East before joining McKinsey & Company, serving blue chip and startup clients across Asia. Next, Wout founded an extreme sports adventure company in Singapore, then spent five years in the high-stakes world of international security, growing and leading a 22,000-headcount organization across four continents into a $500M global player.